Abstract

Various non-adherence behaviors were observed, including patterns of underdosing and taking non-prescribed drugs. Non-adherence was moderate but uniform amongst the treatment groups and may have contributed to a marginal reduction in the power of the primary intent-to-treat analysis to detect differences in efficacy amongst the assigned treatments.

Keywords

MedicineZalcitabineDidanosineRegimenZidovudineDosingInternal medicineClinical trialRandomized controlled trialImmunologyHuman immunodeficiency virus (HIV)Viral disease

Affiliated Institutions

Related Publications

Publication Info

Year
1998
Type
article
Volume
12
Issue
17
Pages
2305-2311
Citations
61
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

61
OpenAlex

Cite This

Helen Kastrissios, José-Ramón Suárez, Scott Hammer et al. (1998). The extent of non-adherence in a large AIDS clinical trial using plasma dideoxynucleoside concentrations as a marker. AIDS , 12 (17) , 2305-2311. https://doi.org/10.1097/00002030-199817000-00012

Identifiers

DOI
10.1097/00002030-199817000-00012